# Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)

> **NCT02294955** · NA · UNKNOWN · sponsor: **Uppsala University Hospital** · enrollment: 152 (actual)

## Conditions studied

- Atrial Fibrillation
- Quality of Life

## Interventions

- **DEVICE:** Catheterablation
- **DRUG:** Amiodarone
- **DRUG:** Sotalol
- **DRUG:** Flecainide
- **DRUG:** Propafenone
- **DRUG:** Disopyramide
- **DRUG:** Dronedarone

## Key facts

- **NCT ID:** NCT02294955
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294955, "Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02294955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*